-
2501
Biomarkers of Joint Damage in Osteoarthritis: Current Status and Future Directions
Published 2021-01-01“…The most unmet clinical need is, however, related to the monitoring of disease progression over a short period that can be used in clinical trials. In this review, the value of biomarkers identified over the past decade has been highlighted. …”
Get full text
Article -
2502
Current Perspective About the Effect of a Ketogenic Diet on Oxidative Stress – a Review
Published 2024-03-01“…An important aspect is the summary of the current knowledge about the effect of KD on OS conducted in vitro, in vivo, and in clinical trials. Finally, the review addresses future studies needed to understand the connection between KD and OS.…”
Get full text
Article -
2503
The Nrf2/Keap1/ARE Pathway and Oxidative Stress as a Therapeutic Target in Type II Diabetes Mellitus
Published 2017-01-01“…Animal studies and clinical trials have shown promising results suggesting that activation of this pathway can delay or reverse some of these impairments in TIIDM. …”
Get full text
Article -
2504
DNA Vaccination: Using the Patient's Immune System to Overcome Cancer
Published 2010-01-01“…Using the patient's own immune system by activation of humoral and cellular immune responses to target the cancer cells has shown first promising results in clinical trials and may allow reduced toxicity standard therapy regimen in the future. …”
Get full text
Article -
2505
Noninvasive Home Mechanical Ventilation for Stable Hypercapnic COPD: A Clinical Respiratory Review from Canadian Perspectives
Published 2023-01-01“…In the past decade, studies utilizing aggressive NIV settings to maximally reduce carbon dioxide levels (PaCO2) have resulted in several positive clinical trials and led to updated guidelines on home NIV for stable hypercapnic COPD patients. …”
Get full text
Article -
2506
CHIMERIC ANTIGEN RECEPTOR T CELLS FOR THE TREATMENT OF MULTIPLE MYELOMA
Published 2024-10-01“…Despite this progress, the efficacy of CAR-T cells in MM is limited by the responsiveness of only a part of the treated patients, the relapse of other patients, the cost of the treatment and the diminished response in patients with prior exposure to anti-BCMA targeting agents. Ongoing clinical trials are evaluating the use of CAR-T cells at an earlier stage of MM disease and the use of CAR-T cells targeting other membrane antigens expressed on malignant plasma cells. …”
Get full text
Article -
2507
Use of complementary and alternative medicine in head and neck cancer: Salutary or noxious
Published 2024-06-01“…Alternatively, patients increasingly explore several other complementary and alternative medicine (CAM) therapies. Though clinical trials of certain CAM modalities have shown effectiveness in managing symptoms and risk behaviours allied with HNC and its treatment, evidence also suggests a need for heed. …”
Get full text
Article -
2508
Tumor metabolic regulators: key drivers of metabolic reprogramming and the promising targets in cancer therapy
Published 2025-01-01“…We also summarize recent clinical trials involving metabolic regulators and the challenges of metabolism-based tumor therapies in clinical translation. …”
Get full text
Article -
2509
Flavocoxid, a Nutraceutical Approach to Blunt Inflammatory Conditions
Published 2014-01-01“…Flavocoxid downregulates gene or protein expression of several inflammatory markers and exerts also strong antioxidant activity in several experimental models. Controlled clinical trials and a postmarketing study have clearly shown that flavocoxid is as effective as naproxen in managing the signs and symptoms of osteoarthritis of the knee and it has better upper gastrointestinal, renal, and respiratory safety profile than naproxen. …”
Get full text
Article -
2510
Review of the clinical status of cardiotoxicity of HER-2 positive breast cancer targeted therapeutic drugs
Published 2025-02-01“…We list the evidence of cardiotoxicity for various drugs based on current clinical trials and summarize their corresponding epidemiological profiles. …”
Get full text
Article -
2511
Targeting RNA splicing modulation: new perspectives for anticancer strategy?
Published 2025-01-01“…Numerous splicing modulators, each utilizing different mechanisms, have been developed as promising anticancer therapies, some of which are in clinical trials. In this review, we summarize the splice-altered signatures of cancer cell transcriptomes and the contributions of splicing aberrations to tumorigenesis and progression. …”
Get full text
Article -
2512
Thrombospondin-1: Multiple Paths to Inflammation
Published 2011-01-01“…The effects of TSP-1 have been studied in many preclinical tumor models, and mimetic peptides are being tested in cancer clinical trials. However, the molecular mechanisms explaining its role in inflammatory processes are not well understood. …”
Get full text
Article -
2513
Successful Treatment of Hepatitis C with Simeprevir, Sofosbuvir, and Ribavirin in an HIV Coinfected Liver Transplant Patient with Advanced Chronic Kidney Disease
Published 2016-01-01“…The new DAAs show promise for HIV coinfected patients and those with severe to end-stage renal disease (ESRD); however, robust clinical trials or large cohort studies will need to be conducted to confirm the efficacy and safety of these newer agents in this setting.…”
Get full text
Article -
2514
Treatment Outcome of Using Guided Bone Regeneration for Bone Augmentation for the Placement of Dental Implants – A Systematic Review
Published 2024-12-01“…Materials and Methods: This review was performed by two reviewers electronically on the PubMed and Cochrane database for articles published between 1990 and 2023. Only randomized clinical trials (RCTs) and prospective studies were included. …”
Get full text
Article -
2515
Outcomes in stage IIA versus stage IIB/III in the PALLAS trial [ABCSG-42/AFT-05/PrE0109/BIG-14-13])
Published 2025-01-01“…Trial Registration ClinicalTrials.gov number NCT02513394 Registered 30 Jul 2015.…”
Get full text
Article -
2516
-
2517
Gene Therapy for HIV Infections: Intracellular Immunization
Published 1999-01-01“…In this context, a number of intracellular immunization-based strategies have been evaluated, and some of them have reached the stage of phase I/II human clinical trials. These strategies include the use of single-chain antibodies, capsid-targeted viral inactivation, transdominant negative mutants, ribozymes, antisense oligonucleotides and RNA decoys. …”
Get full text
Article -
2518
Exploring oncogenic roles and clinical significance of EZH2: focus on non-canonical activities
Published 2025-01-01“…This review also presents the clinical trials in various phases that evaluate the use of EZH2 inhibitors, both as monotherapy and in combination with other agents for the treatment of patients with diverse types of cancers.…”
Get full text
Article -
2519
Dendritic Cell-Based Approaches for Therapeutic Immune Regulation in Solid-Organ Transplantation
Published 2013-01-01“…Genetically engineered DCs have also been tested. Two clinical trials in type-1 diabetes and rheumatoid arthritis have been carried out, and other trials, including one trial in kidney transplantation, are in progress or are imminent.…”
Get full text
Article -
2520
Asthma “Control”
Published 2004-01-01“…There are excellent data from clinical trials (3) that inhaled steroids work, and in population studies (4), their use is associated with improved survival.…”
Get full text
Article